1-((1r,4r)-4-(2-(4-(2,3-Dichloro-4-hydroxyphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-methylurea
- CAS
- 1084891-94-0
- Formula
- C20H30Cl2N4O2
- MW
- 429.39 g/mol
VQ-044057
Impurity reference standards
Cariprazine impurities & reference standards
Characterised Cariprazine impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
58reference materials
1nitrosamine impurities
4isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Cariprazine
839712-12-8 · C21H32Cl2N4O
1-((1r,4r)-4-(2-(4-(2,3-Dichloro-4-hydroxyphenyl)piperazin-1-yl)ethyl)cyclohexyl)urea
- CAS
- 1084891-93-9
- Formula
- C19H28Cl2N4O2
- MW
- 415.36 g/mol
VQ-044058
2-((1r,4r)-4-(3,3-Dimethylureido)cyclohexyl)-N-methoxy-N-methylacetamide
- CAS
- 2268787-30-8
- Formula
- C13H25N3O3
- MW
- 271.36 g/mol
VQ-022022
2-((1r,4r)-4-(3,3-Dimethylureido)cyclohexyl)ethyl 4-methylbenzenesulfonate
- CAS
- 1698050-46-2
- Formula
- C18H28N2O4S
- MW
- 368.5 g/mol
VQ-022019
3-((1s,4s)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-diethylurea
- Formula
- C23H36Cl2N4O
- MW
- 455.46 g/mol
In stock
4-(2,3-Dichlorophenyl)-N,N-dimethylpiperazine-1-carboxamide
- CAS
- 2327471-74-7
- Formula
- C13H17Cl2N3O
- MW
- 302.2 g/mol
VQ-022021
![Carbamic acid, N-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-, ethyl Ester chemical structure](/media/structures/FTMSDWKPLDIAPU-UHFFFAOYSA-N.svg)
Carbamic acid, N-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-, ethyl Ester
- CAS
- 1957145-61-7
- Formula
- C21H31Cl2N3O2
- MW
- 428.4 g/mol
VQ-044791
Ethyl 2-(4-(3,3-dimethylureido)cyclohexyl)acetate
- CAS
- 2410736-56-8
- Formula
- C13H24N2O3
- MW
- 256.34 g/mol
VQ-047699
Ethyl 2-(cis-4-aminocyclohexyl)acetate Hydrochloride
- CAS
- 76308-13-9
- Formula
- C10H20ClNO2
- MW
- 221.72 g/mol
VQ-024803
Ethyl trans-2-(4-aminocyclohexyl)acetate hydrochloride
- CAS
- 76308-26-4
- Formula
- C10H20ClNO2
- MW
- 221.72 g/mol
VQ-043361
Methyl 2-((1r,4r)-4-aminocyclohexyl)acetate (HCl Salt)
- CAS
- 76308-25-3
- Formula
- C9H18ClNO2
- MW
- 207.7 g/mol
VQ-045419
tert-Butyl (trans-4-(2-oxoethyl)cyclohexyl)carbamate
- CAS
- 215790-29-7
- Formula
- C13H23NO3
- MW
- 241.33 g/mol
VQ-024804
tert-Butyl [cis-4-(2-oxoethyl)cyclohexyl]carbamate
- CAS
- 847417-37-2
- Formula
- C13H23NO3
- MW
- 241.33 g/mol
VQ-029657
trans-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane
- CAS
- 917342-29-1
- Formula
- C13H25NO3
- MW
- 243.34 g/mol
VQ-047698
trans-2-(4-Aminocyclohexyl)acetic acid hydrochloride
- CAS
- 76325-96-7
- Formula
- C8H16ClNO2
- MW
- 193.67 g/mol
VQ-024801
![Trans-4-[[(Dimethylamino)carbonyl]amino]cyclohexaneacetic acid chemical structure](/media/structures/KCZGQVQWQAJXSN-UHFFFAOYSA-N.svg)
Trans-4-[[(Dimethylamino)carbonyl]amino]cyclohexaneacetic acid
- CAS
- 1957145-59-3
- Formula
- C11H20N2O3
- MW
- 228.29 g/mol
VQ-029659
FAQs — Cariprazine impurities
Which Cariprazine impurities do you supply?
We list 58 Cariprazine-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Cariprazine impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Cariprazine impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Cariprazine impurity standards
We reply within one business day with price, pack options, lead time and documentation.